Roswell Park Comprehensive Cancer Center Buffalo, New York
Associate Member Department of Cancer Prevention and Control
Understanding the molecular drivers of aggressive breast cancer in Black women and how these are different in white women.
Black women are 42 percent more likely to die of their breast cancer than white women. Those diagnosed with breast cancer are more likely to be younger than newly diagnosed white women and are two times more likely to be diagnosed with triple-negative breast cancer (TNBC), an aggressive subtype of the disease. Drs. Hong and Ambrosone are investigating several biological and lifestyle factors that may influence the incidence of TNBC in Black women. This work may provide new insights at the population level into why some women develop more aggressive breast tumors so that personalized prevention and treatment can be designed.
Drs. Hong and Ambrosone initiated the North South Breast Cancer Study (NSBCS) to be able perform comparable analyses in both Black women and White women. As of 2025, 2,080 White and 666 Black participants have enrolled in the study and completed interviews and retrieval of tumor tissues from hospitals is ongoing. One question Drs. Hong and Ambrosone are investigating is the role of psychosocial factors in the cause of more aggressive tumors, particularly with a focus on the breast cancer tumor immune microenvironment (TIME). The questionnaire for NSBCS includes several assessments related to stress, worry, coping and resiliency, as well as sleep and financial health. In collaboration with BCRF investigator Dr. Neha Goel at Memorial Sloan Kettering Cancer Center, the team is also evaluating factors related to neighborhood – perceived social cohesion, perceived neighborhood order and disorder and perception of safety while walking, as well as perceived discrimination. Drs. Hong and Ambrosone also formed a collaboration with BCRF investigator Dr. Annette Stanton and included assessments for the Strong Black Woman Syndrome, an archetype of how Black women should act, characterized by emotional restraint, independence, and caretaking. As expected, Black women had higher scores for depression and financial toxicity and had more negative perceptions of their neighborhoods.
Building upon their findings so far, Drs. Ambrosone and Hong will extend and deepen analysis of psychosocial and neighborhood factors in relation to the TIME and breast cancer outcomes. In the coming year, the team will conduct analyses to examine Strong Black Woman Syndrome in depth in the study participants, particularly associations with depression and anxiety. In the coming year, the team will fully evaluate factors associated with Strong Black Woman Syndrome correlated them with other factors in Black women in NSBCS. Additionally, the team is planning to evaluate participant perceptions of their neighborhoods with several measures in the NSBCS survey. Finally, the team will explore data from the Women’s Circle of Health Study (WCHS), which aims to evaluate factors explaining the earlier age at diagnosis and the more aggressive nature of breast cancer among Black women compared to White women. Because the WCHS survey includes the same questions regarding neighborhood perceptions, they will use the genome-wide data collected as part of WCHS to examine how these psychosocial factors affect changes in gene expression.
Dr. Chi-Chen Hong is an Associate Member in the Department of Cancer Prevention and Control within the Division of Cancer Prevention and Population Sciences at Roswell Park. Dr. Hong’s research is focused on breast cancer etiology, survivorship, and prognosis. Specifically, her interests are on the influence of lifestyle, comorbidity, genetics, and immune factors. She has an ongoing prospective cohort study of early stage breast cancer patients to examine issues in breast cancer survivorship, and with colleagues at the Rutgers Cancer Institute of New Jersey and Rutgers University is principal investigator of a study examining the role of obesity and related comorbidities, including asthma and type 2 diabetes, and their management on quality-of-life and breast cancer survival outcomes among African American women, and to elucidate key pathways mediating these associations.
2011
The Play for P.I.N.K. Award
Support research with a legacy gift. Sample, non-binding bequest language:
I give to the Breast Cancer Research Foundation, located in New York, NY, federal tax identification number 13-3727250, ________% of my total estate (or $_____).
Stay in the know with the latest research news, insights, and resources delivered to your inbox.
Follow BCRF on all the major platforms for research news, inspiring stories, and more.